Stay updated on Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Sign up to get notified when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.

Latest updates to the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a site/version release rather than a modification to the underlying study information.SummaryDifference0.0%

- Check24 days agoChange DetectedRevision label on the page updated from v3.5.0 to v3.5.2, reflecting a minor site update rather than changes to study content.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.5.0 has been added and v3.4.3 has been removed. This update does not modify the study details or page content.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision: v3.4.2 was added to the page, and the older operating-status notice (Revision: v3.4.1) was removed.SummaryDifference0.4%

- Check96 days agoChange DetectedAdded a government funding status notice and updated the site revision tag to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

Stay in the know with updates to Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.